Next Article in Journal / Special Issue
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
Previous Article in Journal
Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study
Previous Article in Special Issue
COVID-19 Is Changing Our Understanding of the Neuroscience of Viral Infections: What We Can Do to Prepare for the Future?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities

1
Department of Pathology, Stanford School of Medicine, Stanford University Medical Center, San Francisco, CA 94305, USA
2
Department of Neurosurgery, Bhawani Hospital and Research Center, Birgunj 44300, Nepal
3
Neurosurgery, SpedaliCivili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25100 Brescia, Italy
4
Department of Neurosurgery, Trauma and Gamma-Knife Center, Cannizzaro Hospital, 95100 Catania, Italy
5
Department of Neurosurgery, Azienda Ospedaliera Universitaria Pisana (AOUP), University of Pisa, 56100 Pisa, Italy
*
Author to whom correspondence should be addressed.
Neurol. Int. 2022, 14(2), 391-405; https://doi.org/10.3390/neurolint14020032
Submission received: 21 March 2022 / Revised: 16 April 2022 / Accepted: 22 April 2022 / Published: 24 April 2022

Abstract

Stroke is a fatal morbidity that needs emergency medical admission and immediate medical attention. COVID-19 ischemic brain damage is closely associated with common neurological symptoms, which are extremely difficult to treat medically, and risk factors. We performed literature research about COVID-19 and ischemia in PubMed, MEDLINE, and Scopus for this current narrative review. We discovered parallel manifestations of SARS-CoV-19 infection and brain ischemia risk factors. In published papers, we discovered a similar but complex pathophysiology of SARS-CoV-2 infection and stroke pathology. A patient with other systemic co-morbidities, such as diabetes, hypertension, or any respiratory disease, has a fatal combination in intensive care management when infected with SARS-CoV-19. Furthermore, due to their shared risk factors, COVID-19 and stroke are a lethal combination for medical management to treat. In this review, we discuss shared pathophysiology, adjuvant risk factors, challenges, and advancements in stroke-associated COVID-19 therapeutics.
Keywords: COVID-19; anti-coagulants; ischemia; SARS-CoV-2; therapeutics; neurology; neurosurgery; stroke COVID-19; anti-coagulants; ischemia; SARS-CoV-2; therapeutics; neurology; neurosurgery; stroke

Share and Cite

MDPI and ACS Style

Chavda, V.; Chaurasia, B.; Fiorindi, A.; Umana, G.E.; Lu, B.; Montemurro, N. Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurol. Int. 2022, 14, 391-405. https://doi.org/10.3390/neurolint14020032

AMA Style

Chavda V, Chaurasia B, Fiorindi A, Umana GE, Lu B, Montemurro N. Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurology International. 2022; 14(2):391-405. https://doi.org/10.3390/neurolint14020032

Chicago/Turabian Style

Chavda, Vishal, Bipin Chaurasia, Alessandro Fiorindi, Giuseppe E. Umana, Bingwei Lu, and Nicola Montemurro. 2022. "Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities" Neurology International 14, no. 2: 391-405. https://doi.org/10.3390/neurolint14020032

APA Style

Chavda, V., Chaurasia, B., Fiorindi, A., Umana, G. E., Lu, B., & Montemurro, N. (2022). Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurology International, 14(2), 391-405. https://doi.org/10.3390/neurolint14020032

Article Metrics

Back to TopTop